Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies William Suciangto; Haerani Rasyid; Anastasya Angelica Vicente; Winny Suciangto;

Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM) José-Vicente Torregrosa; Jordi Bover; Mariano Rodríguez Portillo; Emilio González Parra; María Dolores Arenas; Francisco Caravaca; María-Luisa González Casaus; Alejandro Martín-Malo; Juan Francisco Navarro-González; Víctor Lorenzo; Pablo Molina; Minerva Rodríguez; Jorge Cannata Andia;

A predictive model of non-diabetic kidney disease in patients with diabetes mellitus and chronic kidney disease. A Spanish multi-center study Sheila Bermejo; Ester González; Katia López-Revuelta; Meritxell Ibernon; Diana López; Adoración Martín-Gómez; Rosa Garcia-Osuna; Tania Linares; Montserrat Díaz; Nàdia Martín; Xoana Barros; Helena Marco; Maruja Isabel Navarro; Noemí Esparza; Sandra Elias; Ana Coloma; Nicolás Roberto Robles; Irene Agraz; Esteban Poch; Lida Rodas; Víctor Lozano; Beatriz Fernández-Fernández; Eduardo Hernández; Maria Isabel Martínez; Ramona Ionela Stanescu; José Pelayo Moirón; Núria García-Fernández; Marian Goicoechea; Francesca Calero; Josep Bonet; Fernando Liaño; Julio Pascual; Manuel Praga; Xavier Fulladosa; María José Soler;